BR100 Decreased By (-1.39%)
BR30 Decreased By (-1.72%)
KSE100 Decreased By (-1.3%)
KSE30 Decreased By (-1.25%)
AGHA 7.92 Decreased By ▼ -0.17 (-2.1%)
BECO 5.20 Decreased By ▼ -0.07 (-1.33%)
BML 59.25 Decreased By ▼ -0.13 (-0.22%)
BOP 33.68 Decreased By ▼ -0.51 (-1.49%)
CNERGY 9.81 Increased By ▲ 0.19 (1.98%)
CSIL 5.42 Decreased By ▼ -0.08 (-1.45%)
FCCL 53.52 Decreased By ▼ -0.63 (-1.16%)
FFL 16.68 Decreased By ▼ -0.16 (-0.95%)
FNEL 1.21 Decreased By ▼ -0.02 (-1.63%)
KEL 7.35 Decreased By ▼ -0.24 (-3.16%)
KOSM 5.61 Decreased By ▼ -0.07 (-1.23%)
LOTCHEM 29.11 Decreased By ▼ -1.32 (-4.34%)
MLCF 95.50 Decreased By ▼ -2.66 (-2.71%)
NBP 204.35 Decreased By ▼ -4.44 (-2.13%)
NCPL 58.24 Decreased By ▼ -1.37 (-2.3%)
NPL 67.79 Decreased By ▼ -2.08 (-2.98%)
OGDC 317.94 Decreased By ▼ -5.42 (-1.68%)
PACE 10.71 Decreased By ▼ -0.36 (-3.25%)
PAEL 41.83 Decreased By ▼ -0.42 (-0.99%)
PIBTL 16.50 Decreased By ▼ -0.32 (-1.9%)
PPL 219.74 Decreased By ▼ -4.99 (-2.22%)
PRL 44.59 Increased By ▲ 2.94 (7.06%)
PTC 70.77 Decreased By ▼ -0.35 (-0.49%)
SSGC 28.93 Decreased By ▼ -0.38 (-1.3%)
TBL 9.84 Decreased By ▼ -0.12 (-1.2%)
TELE 8.76 Decreased By ▼ -0.23 (-2.56%)
TPL 16.45 Decreased By ▼ -0.07 (-0.42%)
TPLP 12.10 Decreased By ▼ -0.67 (-5.25%)
TREET 22.80 Decreased By ▼ -0.26 (-1.13%)
TRG 60.03 Decreased By ▼ -0.42 (-0.69%)

ISLAMABAD: The Competition Commission of Pakistan (CCP) has granted approval for the acquisition of a certain shareholding in Route2Health (Private) Limited by AZT Foundation from Tausif Ahmad Khan, Zainub Abbas, and Javaid Hussain, under a Share Purchase Agreement.

AZT Foundation, a UAE-based organization, was established for the purpose of holding and managing the assets on behalf of the aforementioned individuals (sellers). Route2Health (Pvt) Limited is engaged in the business of manufacturing, marketing, and distribution of nutraceuticals and health supplements in Pakistan.

Following a detailed competitive analysis, the CCP identified the relevant product market as ‘Nutraceutical and Herbal Supplements’. The transaction has been classified as a conglomerate merger, as there are no horizontal or vertical overlaps between the acquirer and the target.

The Commission concluded that the transaction would not result in the creation or strengthening of a dominant position in the relevant market. Hence, the CCP has approved the transaction in accordance with Section 11 of the Competition Act, 2010.

Copyright Business Recorder, 2025

Comments

Comments are closed for this article.